Inpharma Weekly

, Volume 1114, Issue 1, pp 13–14 | Cite as

Extrafine CFC-free beclomethasone aerosol hits the right spot

  • Wayne Elwood
Newsletter Article
  • 3 Downloads

Abstract

Inhaled corticosteroids are the gold standard anti-inflammatory therapy for patients with asthma. Currently, only a small proportion of the inhaled corticosteroid dose is actually delivered to the site of inflammation in the airways. Recent moves towards environmentally friendly chlorofluorocarbon (CFC)-free inhaler devices have presented an opportunity to refine, and better target, corticosteroid aerosol delivery to the lungs. The favourable characteristics and clinical potential of a new CFC-free beclomethasone extrafine aerosol were discussed at a 3M-sponsored symposium at the Annual Congress of the European Respiratory Society [ Berlin, Germany; September 1997 ].

Keywords

Beclomethasone Peak Expiratory Flow Rate Lung Deposition European Respiratory Society Local Adverse Effect 

Copyright information

© Adis International Ltd 1997

Authors and Affiliations

  • Wayne Elwood

There are no affiliations available

Personalised recommendations